ClinicalTrials.govpublic full text
Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)
metastatic prostate cancer, metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer, lutetium (177lu) vipivotide tetraxetan injection, non-interventional study, china, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 836712
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.